The effect of the MAPT c.855C>T (p.Asp285Asp) change on levels of τp-181 in the FTD/ALS cohort we studied suggests that this variant could be an indirect modifier of tau phosphorylation (e.g., by affecting mRNA processing) and thus of pathophysiological significance. Here, MAPT is linked to amyotrophic lateral sclerosis.